← Back to headlines
Eli Lilly Launches Alzheimer's Drug Donanemab in India
Pharmaceutical company Eli Lilly has launched its Alzheimer's drug, donanemab, in India, making it available for patients in the country.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
